Showing results (491-500 of 661) with videos related to
Sort By:
Pageof 67
BMC Cancer|April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trialsMairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.European Journal of Cancer (Oxford, England : 1990)|July 7, 2026
The clinical relevance of regional lymph node microarchitecture in oesophageal cancer patients - Results from the UK MRC OE02 trialMaximilian Kloft, Elzbieta Budginaite, Henry C Woodruff, et al.European Journal of Cancer (Oxford, England : 1990)|January 22, 2014
Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumoursTim Meyer, Wendi Qian, Martyn E Caplin, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 17, 2025
Characteristics of Ipsilateral Corticomotor Pathways in People with cervical spinal cord InjuryJia Liu, Madeline Cantu, Kyle O'Laughlin, et al.Lancet (London, England)|April 26, 2013
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cyclesDavid Cunningham, Eliza A Hawkes, Andrew Jack, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2018
BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET StudyThomas Kaley, Mehdi Touat, Vivek Subbiah, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 1, 2021
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trialCharles S Fuchs, Mustafa Özgüroğlu, Yung-Jue Bang, et al.British Journal of Cancer|May 30, 2018
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH studyIan Chau, Joon Oh Park, Baek-Yeol Ryoo, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 3, 2022
Cost and clinical benefit of imaging surveillance after treatment for breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)Rachel L O'Connell, Bhupinder Sharma, Liza Van Kerckhoven, et al.The American Journal of Cardiology|September 28, 2015
Comparative survival after transapical, direct aortic, and subclavian transcatheter aortic valve implantation (data from the UK TAVI registry)Georg M Fröhlich, Paul D Baxter, Christopher J Malkin, et al.Pageof 67